ArticleResearch (Washington, D.C.)2025

Luteolin Nanomedicine with Stimulus-Driven Traceless Release for Targeting Treatment of Atherosclerosis by Enhancing Lipid Efflux.

Songzan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.